Certainly, pSAD-based minigenes represented valuable tools to functionally check variants of the SERPINA1 (severe alpha-1 antitrypsin deficiency) and CHD7 (Charge Syndrome) genes (Lara et al., 2014; Villate et al., 2018). The gene discussed is CHD7; the disease is CHARGE syndrome.